Stratification
[대역어] 층화
[용어속성] Term
[용어속성] Term
Quantitative CT imaging and advanced visualization methods: potential application in novel coronavirus disease 2019 (COVID-19) pneumonia
Practice and Policy
[키워드] Accuracy
airway
airways disease
Analysis
Anatomy
approaches
Asthma
Blood
Care
change
chronic obstructive
classical
clinically
Computed tomography
COVID-19
Diagnosis
disease
disease phenotype
fibrosis
functional
highlight
include
Inflammatory
inflammatory lung disease
Interstitial lung disease
Intervention
lung
Lung diseases
Lung function
measure
Metrics
morbidity
novel coronavirus disease
offer
parenchymal
Phenotypes
Pneumonia
Prognosis
progression
protocol
pulmonary disease
pulmonary diseases
Quantitative
severity
Stratification
utility
Vascular
Volume
yielding
[DOI] 10.1259/bjro.20200043 PMC 바로가기 [Article Type] Practice and Policy
[DOI] 10.1259/bjro.20200043 PMC 바로가기 [Article Type] Practice and Policy
Evaluation and improvement of the National Early Warning Score (NEWS2) for COVID-19: a multi-hospital study
COVID-19에 대한 국가 조기 경보 점수(NEWS2) 평가 및 개선: 다중 병원 연구
Multicenter Study
[키워드] (hypertension
95% CI
95% confidence interval
age
AUC
baseline
Biomarkers
Blood
Blood parameters
Bristol
C-reactive protein
cardiovascular
characteristic
Cohort
collected
college
Comorbidities
Comorbidity
COVID
COVID-19
COVID-19 disease
COVID-19 infection
COVID-19 patients
death
detect
diabetes
disease
Early warning score
eight
estimated glomerular filtration rate
Ethnicity
evaluate
Evidence
evidence of
External
filtration rate
FIVE
flow rate
foundation
glomerular filtration rate
highlight
hospital
Hospital admission
hypertension
ICU
identify
IMPROVE
improvement
intensive care
intensive care unit
kidney
Kidney diseases
Measures
National Early Warning Score
National Health Service
neutrophil
neutrophil count
neutrophil/lymphocyte ratio
NEWS2
NEWS2 score
NHS
Norway
outcome
oxygen
oxygen saturation
parameter
Patient
physiological
Prediction model
question
raise
receiver
receiver operating characteristic
replicated
respiratory
Result
risk
risk stratification
score
Seven
severe cases
severe COVID-19
severe COVID-19 disease
Severe COVID-19 Infection
Sex
Stratification
supplemental oxygen
supplementary material
Tongji Hospital
training
transfer
Trust
university
University College London
urea
validation cohort
with COVID-19
Wuhan
Wuhan, China
[DOI] 10.1186/s12916-020-01893-3 PMC 바로가기 [Article Type] Multicenter Study
[DOI] 10.1186/s12916-020-01893-3 PMC 바로가기 [Article Type] Multicenter Study
Prognostic Implications of Chronic Heart Failure and Utility of NT-proBNP Levels in Heart Failure Patients with SARS-CoV-2 Infection
Article
[키워드] 30-Day mortality
Admission
age and sex
all-cause mortality
Biomarkers
Brain
chronic
chronic heart failure
Cohort
confidence interval
consecutive patient
coronavirus
coronavirus 2
COVID-19
failure
hazard ratio
heart
heart failure
implication
Infection
Level
Mortality
N Terminal
NT-proBNP
Patient
patients hospitalized
peptide
Prevalence
Prognosis
Prognostic value
respiratory
risk
SARS-CoV-2
SARS-COV-2 infection
single-center study
Stratification
troponin
[DOI] 10.3390/jcm10020323 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jcm10020323 PMC 바로가기 [Article Type] Article
Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients
혈액 전사체의 질병 중증도별 호중구 서명은 COVID-19 환자를 계층화합니다
Research
[키워드] acute respiratory distress
acute respiratory distress syndrome
analyzed
Asymptomatic
available data
blood cell
blood transcriptome
Blood transcriptomics
capture
Cell
changes in
clinical
Clinical parameters
Clinical presentations
Co-expression analysis
Cohort
Combination
control sample
COVID-19
COVID-19 patient
data-driven
death
disease severity
dissect
Donor
driver
drug candidate
drug candidates targeting
Drug repurposing
drug target
dysregulated
explained
granulocyte
granulocyte sample
Granulocytes
groups
Host
host responses
identify
immune
immune system
independent
Infection
Inflammatory diseases
Mild
mild respiratory
mild respiratory tract infection
Molecular disease phenotypes
molecular phenotype
molecular subgroup
neutrophil
neutrophil activation
Neutrophil activation-associated signature
Neutrophils
other diseases
parameters
Patient
performed
phenotype
Phenotypes
predicted
provide
report
respiratory
respiratory distress
Respiratory failure
respiratory tract infection
Result
RNA-Seq
SARS-CoV-2 pandemic
Severe case
severe cases
severe COVID-19 patient
Severe patient
Stratification
stratified
supplementary material
syndrome
systemic immune response
Transcriptome
transcriptomes
Viral
viral infections
was used
Whole blood
whole blood transcriptome
PMC 바로가기 [Article Type] Research
PMC 바로가기 [Article Type] Research
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial
COVID-19 폐렴 환자에서 호흡 악화 예방을 위한 BIO101의 효능 및 안전성 테스트(COVA 연구): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
20-hydroxyecdysone
absence
accumulation
ACE2
Activation
acute respiratory distress
acute respiratory distress syndrome
adaptive
addition
administration
Airway Pressure
all-cause mortality
ALT
Alter
amenorrhea
Analysis
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme 2
Angiotensin converting enzyme-2
Anti-inflammatory
anticipated
approved
ARDS
arterial oxygen saturation
AST
Asymptomatic
balance
baseline
being
Belgium
beneficiary
Bilirubin
BIO101
Biomarker
Biomarkers
birth control
blinded
Brazil
breath
Cardiomyopathy
Care
Caregivers
caused
clinical development
Clinical finding
Clinical findings
clinical picture
co-morbidities
co-morbidity
collected
Compliance
condition
condom
conducted
confirmation
Consumption
Continuous
Continuous Positive Airway Pressure
Contraception
contraceptive method
coronavirus disease
COVID-19
COVID-19 infection
COVID-19 infection symptom
COVID-19 infection symptoms
COVID-19 patient
COVID-19 patients
criteria
criterion
daily dose
Day
death
defined
Department
Deterioration
develop
diabetes
diagnosis of COVID-19
dialysis
discharge
discharged
disease
dissemination
DMC
dose
double-blind
downstream
ECMO
Effect
effective
Efficacy
Efficacy and safety
EGFR
element
eligible participant
Eligible participants
endotracheal tube
Endpoint
enzyme
etonogestrel
EudraCT
European
evaluate
event
Evidence
evidence of
exclusion criteria
expected
exploratory
extracorporeal membrane oxygenation
female
female participants
Final
FiO2
Flow
following
form
France
French
functional
Gault
Gender
healthcare
healthcare facility
heart disease
High-flow oxygen
higher risk
hospital
hospital care
Hospitalization
Hospitalized
hypersensitivity
hypertension
IBM
ICF
Imbalance
include
Inclusion
independent
indication
Infection
Inflammation
informed consent form
injection
Interim analyses
interim analysis
Intervention
intrauterine device
Intubated
Invasive mechanical ventilation
IWRS system
lactating
limit
Liver function
liver function tests
male participants
marker
Mas receptor
maximum
measure
mechanical ventilation
medical intervention
medication
medications
minute
moderate
morbidities
Moribund
Mortality
mouth
Multiorgan dysfunction
muscles
myocarditis
negative urine pregnancy test
Non-COVID-19
number
obesity
objective
observation
offer
Older
oral contraceptive
outcome
outlined
oxygen
Part
participant
partner
pathway
Pathways
patients with COVID-19
patients with SARS-CoV-2
PCR
performed
Pericarditis
Physical examination
Placebo
placebo-controlled
Pneumonia
positive airway pressure
post-intervention
post-menopausal
powder
pregnancy test
pressure
primary endpoint
proof
proportion
Proportion of participant
protocol
public health
randomised
randomised controlled trial
randomization
RAS
reached
receive
receiving
receptor
recruited
recruitment
Registered
renal
renal disease
renal insufficiency
Renin
renin angiotensin system
renin-angiotensin system
reproduction
required
resource
respiratory
Respiratory distress syndrome
Respiratory failure
Respiratory function
respiratory symptoms
restored
risk
Sample size
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV2
SARS-CoV2 spike protein
second
secondary
secondary endpoint
security
severe pneumonia
Shock
Social Security
specimen
Sperm
Spike protein
SpO2
Statistical power
status
Sterilization
Stratification
stratified
study medication
Study protocol
supplementary material
survival
suspicion
Symptom
syndrome
tachypnea
target population
tested
Testing
the primary endpoint
therapeutic
therapeutic option
tissue
Tolerability
Total
total bilirubin
Treatment
treatment arm
treatment period
Triage
Trial
Trial registration
ULN
Urine
USA
variety
vasectomy
Version
Viral load
water
website
[DOI] 10.1186/s13063-020-04998-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04998-5 PMC 바로가기 [Article Type] Letter
Transcriptomic Analysis of Respiratory Tissue and Cell Line Models to Examine Glycosylation Machinery during SARS-CoV-2 Infection
SARS-CoV-2 감염 중 당화 기계를 검사하기 위한 호흡기 조직 및 세포주 모델의 전사체 분석
Article
[키워드] addition
affecting
Analysis
approach
biological significance
Biomarker
correlation
COVID-19 immunity
cytokine
Cytokine storm
database
differentially expressed
downstream
epitope
Epitopes
expression
functional
functional enrichment
Functional genomics
glycan
glycans
glycosylation
glycosylation pathway
glycosylation pathways
Host immune response
host inflammatory response
hypothetical
immune function
immune response
immunomodulatory
implicated
in silico
Infection
infectious agents
inflammatory signaling
LINE
Localization
macromolecule
macromolecules
marker
Model
modulated
modulating
negative and positive
pathogen
Pathways
performed
post-translational modification
Protein
Proteoglycan
proteoglycans
receptor
Repository
respiratory
SARS-CoV-2
SARS-COV-2 infection
Stratification
susceptibility
therapeutic
Transcription
transcriptomic analysis
Treatment
Viral
[DOI] 10.3390/v13010082 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v13010082 PMC 바로가기 [Article Type] Article
Survival Factors and Metabolic Pathogenesis in Elderly Patients (≥65) With COVID-19: A Multi-Center Study
Medicine
[키워드] age
Algorithm
Analysis
applied
ARDS
assist
Characteristics
clinical
clinical end point
clinical stratification
clinically
collected
COVID-19
COVID-19 infection
Deceased
discharged
distress
elderly
Elderly patient
elderly patients
elevated
Factor
Factors
fatty
Follow-up
hospital
hospital discharge
increased risk
infected with COVID-19
interferon
laboratory data
laboratory-confirmed
mechanism
metabolic
metabolic pathogenesis
metabolic pathway
metabolism
molecular
Mortality
Multivariate analysis
Neutrophil-to-lymphocyte ratio
pathogenesis of SARS-CoV-2
pathogenic
pathway flux
Pathways
Patient
patients
performed
potential risk
predict
probability of survival
Prognostic factors
pyruvate
receiving
reported
Risk factors
Stratification
survival
survival factors
survived
survivor
syndrome
Treatment
Vaccine development
with COVID-19
Wuhan
[DOI] 10.3389/fmed.2020.595503 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2020.595503 PMC 바로가기 [Article Type] Medicine
Immunological alternation in COVID-19 patients with cancer and its implications on mortality
Observational Study
[키워드] Analysis
B cells
Cancer
CD4
CD8
cells
Chinese
clinical
Cohort
cohorts
conducted
COVID-19
COVID-19 infection
COVID-19 patient
Cox regression
cytokine
dysregulated immune response
elevated
evaluate the effect
greater
had more
High-sensitivity C-reactive protein
IL-6
IL-8
immune
Immune cell
immune dysregulation
immune response
immune system
immunological
immunological characteristics
implication
increased mortality
independent risk factor
Inflammatory factor
investigated
Logistic regression
malignancy
Mortality
mortality rate
mortality risk
NK cells
Patient
patients
patients hospitalized
poor prognosis
procalcitonin
Prognosis
receptor
Registered
registry
regressions
remained
retrospective cohort study
risk of COVID-19
SARS-CoV-2
significantly
significantly higher
Stratification
susceptible
T cells
those without cancer
with COVID-19
[DOI] 10.1080/2162402X.2020.1854424 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1080/2162402X.2020.1854424 PMC 바로가기 [Article Type] Observational Study
Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial
중등도에서 중증의 COVID-19(NACOVID) 치료를 위한 nitazoxanide + atazanavir/ritonavir의 효능 및 안전성: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Comparative Study
[키워드] 1:1
24 hour
24 hours
achievement
addition
Administered
African
age
allocation
anticipated
antiretroviral drugs
antiviral activity
approval
Atazanavir
atazanavir/ritonavir
Blinding
Care
clinical
Clinical improvement
Clinical management
Comorbidities
confirmation
Control
control group
COVID-19
COVID-19 diagnosis
COVID-19 infection
criteria
defined
determined by
diagnosed
Diagnosis
discharge
dissemination
drug
Drug administration
drugs
Efficacy and safety
element
eliminated
enrolment
exclusion criteria
food
Food and Drug Administration
Gender
group
hospital
hypersensitivity
include
inclusion criteria
Infectious diseases
information
initiation of treatment
Interaction
intervention group
Isolation
lactating
mechanical ventilation
medication
moderate
moderate to severe
multicentre
Nasopharyngeal swab
negativity
Nigeria
nitazoxanide
number
objective
Ogun
once daily
Open-label
open-label trial
Ordinal Scale
outcome measure
Pan
Pan African Clinical Trials Registry
participant
Patient
PCR
PCR test
Phase 2
physician
polymerase chain
polymerase chain reaction
positive
pregnant
Proportion of participant
protocol
quantified
randomisation
randomised
randomised controlled trial
receive
receiving
recruited
REDCap
Registered
registry
reported
Ritonavir
RT-PCR
Saliva
Sample size
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 PCR
SARS-CoV-2 polymerase chain reaction
SARS-CoV-2 viral load
secondary care
sequence
severe COVID-19
specialist
Standard
Standard of care
state
Stratification
Study protocol
supplementary material
symptomatic
Teaching
Temporal
the WHO
time
Treatment
Trial
Trial registration
university
Viral
Viral load
website
working
[DOI] 10.1186/s13063-020-04987-8 PMC 바로가기 [Article Type] Comparative Study
[DOI] 10.1186/s13063-020-04987-8 PMC 바로가기 [Article Type] Comparative Study